6949 — Pell Bio Med Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD8.62bn
- TWD7.70bn
- TWD18.03m
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -189 | -231 | -401 |
Depreciation | |||
Amortisation | |||
Non-Cash Items | 26.4 | 45.8 | 138 |
Unusual Items | |||
Equity in Net Earnings/Losses | |||
Other Non-Cash Items | |||
Changes in Working Capital | 24.5 | -6.59 | 37.6 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -108 | -161 | -180 |
Capital Expenditures | -14.5 | -8.49 | -16.5 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 98.4 | -542 | -403 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 83.9 | -551 | -420 |
Financing Cash Flow Items | — | 15 | 0 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | -5.23 | 769 | 595 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | -29.2 | 56.6 | -4.73 |